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Abstract
Objectives To determine whether specialist nurse
intervention improves outcome in patients with
chronic heart failure.
Design Randomised controlled trial.
Setting Acute medical admissions unit in a teaching
hospital.
Participants 165 patients admitted with heart failure
due to left ventricular systolic dysfunction. The
intervention started before discharge and continued
thereafter with home visits for up to 1 year.
Main outcome measures Time to first event analysis
of death from all causes or readmission to hospital
with worsening heart failure.
Results 31 patients (37%) in the intervention group
died or were readmitted with heart failure compared
with 45 (53%) in the usual care group (hazard
ratio = 0.61, 95% confidence interval 0.33 to
0.96).Compared with usual care, patients in the
intervention group had fewer readmissions for any
reason (86 v 114, P = 0.018), fewer admissions for
heart failure (19 v 45, P < 0.001) and spent fewer days
in hospital for heart failure (mean 3.43 v 7.46 days,
P = 0.0051).
Conclusions Specially trained nurses can improve the
outcome of patients admitted to hospital with heart
failure.
Introduction
Chronic heart failure is a huge public health problem.
Patients have a worse prognosis than those with most
cancers and require frequent, prolonged, and costly
admissions to hospital.1 2 Readmission rates are also
high, and the burden of illness and related expenditure
is set to increase considerably in the future.1
Heart failure is not managed optimally.3 4 Most
patients are not looked after by specialists and have
little knowledge of their condition and its treatment.
Effective therapies are underprescribed.3 4 Patients are
rarely prescribed exercise or given dietary advice or
immunisation against influenza and pneumococcus.
Patients often do not adhere to their drugs.3 4 Many
hospital admissions may therefore be avoidable.3 4
Specialist nurses may help overcome the deficien›
cies in care of patients with heart failure.5 6 We describe
a randomised controlled trial to determine whether
nurse intervention, when used in addition to routine
care, can reduce the morbidity and mortality related to
chronic heart failure. We randomised patients man›
aged by general physicians and general practitioners,
who care for most people with chronic heart failure.
Participants and methods
Participants
Patients who were admitted as an emergency to the
acute medical admissions unit at the Western Infirmary,
Glasgow, with heart failure due to left ventricular systolic
dysfunction were eligible for this study. Patients were
recruited between March 1997 and November 1998 and
followed up for a mean of 12 months. We excluded
patients who were unable or unwilling to give informed
consent or to comply with the intervention and those
who had an acute myocardial infarction, comorbidity
(such as malignancy) likely to lead to death or readmis›
sion in the near future, planned discharge to long term
residential care, or residence outside the hospital’s
catchment area. Echocardiographic left ventricular
systolic function was graded semiquantitatively (normal
or mildly, moderately, or severely reduced) in keeping
with the hospital’s usual practice.
Randomisation
Eligible patients who gave consent were randomised to
usual care or nurse intervention. Study nurses phoned
the Robertson Centre for Biostatistics and the patient
was allocated to one or other intervention group from
a randomisation list. The study was approved by both
the local hospital and general practice ethics
committees.
Intervention
Patients in the usual care group were managed as usual
by the admitting physician and, subsequently, general
practitioner. They were not seen by the specialist
nurses after hospital discharge.
Details of the nurse intervention are published
elsewhere.5 6 Essentially, it consisted of a number of
planned home visits of decreasing frequency, supple›
mented by telephone contact as needed. The aim was
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to educate the patient about heart failure and its treat›
ment, optimise treatment (drugs, diet, exercise),
monitor electrolyte concentrations, teach self monitor›
ing and management (especially the early detection
and treatment of decompensation), liaise with other
health care and social workers as required, and provide
psychological support.
The nurses were given training in these roles
before the start of the study. They used written
protocols on the use of angiotensin converting enzyme
inhibitors, diuretics, and digoxin in chronic heart
failure and liaised with members of the department of
cardiology as required. Participants were given a
pocket sized booklet containing an explanation of
heart failure and its treatment; dietary advice; contact
details for the heart failure nurses; a list of their drugs,
weights, and blood test results; and details of planned
visits (dates and times).
End points and statistical analysis
The primary end point of this study was death from all
causes or hospital admission for heart failure (emer›
gency or elective). The estimated rate of this end point
was 55% at one year in the usual care group. With 82
patients in each treatment group we had an 80% power
at a significance of 5% to detect an absolute difference of
23%—that is, a rate in the nurse intervention group of
32%). The reduction in relative risk of 42% was
predicted from earlier studies of nurse intervention.7–9
Secondary end points included death or hospital
admission for any reason, hospital admission for wors›
ening chronic heart failure, and all cause admission to
hospital. We also analysed numbers of patients admit›
ted, number of admissions, and days spent in hospital.
We obtained data on admissions and deaths from
the hospital records department, the information and
statistics division of the Scottish NHS (hospital admis›
sions) and the Registrar General’s Office, Scotland
(deaths).2 All hospital admissions were adjudicated
blind to treatment allocation.
We compared rates of death, death or readmission,
and cause specific readmission between the groups on
a time to first event basis using the log rank test. We
calculated 95% confidence intervals for hazard ratios
from Cox proportional hazard models with treatment
as the sole covariate. For the outcome of death before
discharge, we compared the results using Fisher’s
exact test. Rates of readmission were compared by
Poisson regression, with adjustment for the length of
follow up. We compared the numbers of days spent in
hospital using bootstrap two sample t tests. The data
were first transformed by taking natural logarithms of
the length of stay in days plus one day. Bootstrap 95%
confidence intervals were calculated for the differ›
ences between the group means of the transformed
data. We used the natural exponentials of the
estimates and end points of the confidence intervals
for presentation purposes, so that they could be inter›
Registered or eligible patients
(n=361)
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(n=165)
Received standard intervention
("usual care") as allocated (n=75)
Did not receive standard
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(n=75)
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(n=0)
Completed trial
(n=75)
* 6 patients died before discharge
† 1 patient died before discharge, and 1 had liver cancer diagnosed, was
      discharged to a hospice, and died shortly thereafter
† 1 patient was discharged to a longterm convalescent home and did not
      receive nurse intervention
Received intervention ("specialist
nurse") as allocated (n=82)
Did not receive
intervention as allocated (n=2)†
Followed up
(n=81)
Withdrawn
(n=1)
Completed trial
(n=81)†
Not randomised
(n=196)
No left venticular systolic dysfunction 184
Refused 12
Fig 1 Patient distribution in trial
Table 1 Clinical characteristics of patients randomised to usual
care or nurse intervention. Values are numbers (percentages)
unless stated otherwise
Usual care
(n=81)
Nurse
intervention
(n=84)
Mean (SD) age (years) 75.6 (7.9) 74.4 (8.6)
Male 41 (51) 54 (64)
Living alone 38 (47) 37 (44)
Social services required 28 (35) 28 (33)
Other medical problems:
Angina 40 (49) 38 (45)
Past myocardial infarction 41 (51) 46 (55)
Diabetes mellitus 15 (19) 15 (18)
Chronic lung disease 18 (22) 23 (27)
Hypertension 42 (52) 36 (43)
Atrial fibrillation* 24 (30) 29 (35)
Valve disease 12 (15) 15 (18)
Past admission for chronic heart failure 36 (44) 27 (32)
New York Heart Association class at admission†:
II 16 (20) 19 (23)
III 33 (42) 28 (34)
IV 30 (38) 36 (43)
Degree of left ventricular systolic dysfunction‡:
Mild 10 (13) 18 (22)
Moderate 42 (53) 31 (38)
Severe 28 (35) 32 (40)
Renal function at admission*:
Median (interquartile range) plasma urea
(mmol/l)
9.7 (6.5›13.9) 8.1 (6.0›10.3)
Median (interquartile range) plasma
creatinine (ìmol/l)
116 (90›168) 108 (84›132)
Mean (SD) blood pressure at discharge (mm Hg)§:
Systolic 126.1 (21.4) 116.0 (19.5)
Diastolic 70.1 (12.0) 68.4 (10.2)
*Information available on 79 of the usual care and 82 of the nurse intervention
group.
†Information available on 79 of the usual care group.
‡Information available on 80 of the usual care and 81 of the nurse intervention
group.
§Information available on 74 of the usual care and 79 of the nurse intervention
group.
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preted as ratios. We used the Kaplan›Meier method to
construct estimated survival curves.
Results
We screened 801 patients thought to have heart failure
on admission. Of the 361 who were eligible for the
study and survived to have echocardiography, 177
(49%) had left ventricular systolic dysfunction. Of
these, 165 gave consent and were randomised, 81 to
the usual care group and 84 to the nurse intervention
group (fig 1). Table 1 shows their clinical characteristics.
By discharge, more patients in the intervention
group than the usual care group had started an angio›
tensin converting enzyme inhibitor and stopped a cal›
cium channel blocker (table 2). Length of hospital stay
(median, interquartile range) was shorter in the
intervention group (median 8.0 (interquartile range
4›10) days v 9.0 (7›12) days in usual care group). The
median (interquartile range) time until death or end of
study was 365 (277›365) days in the usual care group
and 365 (273›365) days in the intervention group.
Table 3 summarises the clinical results. Death rates
were similar in the two groups, with 31% and 30%
dying in the usual care and nurse intervention groups,
respectively. For our primary end point (all cause death
or admission with chronic heart failure) fewer patients
had events in the nurse intervention group than in the
usual care group (31 v 43; hazard ratio = 0.61, 95%
confidence interval 0.38 to 0.96). Figure 2 shows the
Kaplan›Meier curve.
Death or readmission from all causes was reduced
by 28% (0.72, 0.49 to 1.04) in the nurse intervention
group compared with usual care (table 3). The risk of
admission to hospital for worsening heart failure was
reduced by 62% (0.38, 0.19 to 0.76) in the intervention
group.
When we took the number of readmissions for
each patient into account, the differences between the
treatment groups were greater (table 3). The number of
admissions/patient/month was 0.174 in the usual care
group and 0.124 in the intervention group (rate ratio
0.71, 95% confidence interval 0.54 to 0.94) for all cause
admissions; the corresponding rates for admission for
heart failure were 0.069 and 0.027 (0.40, 0.23 to 0.71).
Discussion
We found that intervention by a specialist nurse can
substantially reduce the risk of readmission to hospital
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Fig 2 Time to first event (death from any cause or hospital admission
for heart failure) in usual care and nurse intervention groups
Table 2 Drug treatment on admission and at hospital discharge in usual care and nurse intervention groups
Usual care Nurse intervention
Admission (n=81) Discharge (n=74) Admission (n=84) Discharge (n=81)
No (%) taking drug:
Loop diuretic 55 (69) 68 (92) 53 (63) 76 (94)
Thiazide diuretic 5 (6) 4 (5) 8 (10) 5 (6)
ACE inhibitor 41 (51) 53 (72) 35 (42) 65 (80)
Digoxin 15 (19) 31 (42) 16 (19) 35 (43)
â blocker 10 (12) 5 (7) 11 (13) 2 (2)
Oral or transdermal nitrate 22 (28) 26 (35) 19 (23) 21 (26)
Calcium channel blocker 22 (28) 17 (23) 15 (18) 8 (10)
Median (interquartile range) dose (mg):
Furosemide (frusemide) equivalent* 80 (40›120) 80 (40›120) 80 (40›120) 80 (65›120)
Enalapril equivalent† 10 (10›20) 10 (10›20) 15 (10›20) 20 (6.3›20)
Digoxin 0.125 (0.125›0.1875) 0.125 (0.125›0.1875) 0.125 (0.125›0.1875) 0.125 (0.125›0.25)
Median (interquartile range) No of drugs 5 (3›7) 6 (4.8›8) 4 (3›6) 5 (4›7)
ACE=angiotensin converting enzyme.
*Based on patients taking loop diuretics.
†Based on patients taking angiotensin converting enzyme inhibitor. Data available for 35 of usual care group and 33 of intervention group at admission and for 45
and 60 respectively at discharge.
Table 3 Clinical events in usual care and nurse intervention groups
Usual care
(n=81)
Nurse
intervention
(n=84)
Effect of nurse
intervention relative to
usual care (95% CI) P value
No (%) of deaths
Before discharge 6 (7) 1 (1) — 0.061
Total 25 (31) 25 (30) 0.93 (0.54 to 1.63)* 0.81
No (%) of patients readmitted
All causes 49 (60) 47 (56) 0.80 (0.53 to 1.19)* 0.27
Worsening heart failure 26 (32) 12 (14) 0.38 (0.19 to 0.76)* 0.0044
No (%) of deaths or readmissions
All causes 61 (75) 52 (62) 0.72 (0.49 to 1.04)* 0.075
Heart failure 43 (53) 31 (37) 0.61 (0.38 to 0.96)* 0.033
No of readmissions (No/patient/month)
All causes 114 (0.174) 86 (0.124) 0.71 (0.54 to 0.94)† 0.018
Worsening heart failure 45 (0.069) 19 (0.027) 0.40 (0.23 to 0.71)† 0.0004
Mean (SD) No of days in hospital
All causes 16.7 (24.1) 10.3 (19.0) 0.65 (0.40 to 1.06)‡ 0.081
Worsening heart failure 7.46 (16.6) 3.43 (12.2) 0.60 (0.41 to 0.88)‡ 0.0051
All causes refers to unplanned and planned admissions.
*Hazard ratio.
†Rate ratio.
‡Confidence interval for difference in mean loge(duration of hospital stay +1) retransformed to a ratio scale.
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for heart failure. Although 16 fewer primary events
occurred per 100 patients treated, the benefit was
solely related to hospital admissions and not deaths, as
would be expected in a small study with a relatively
short follow up. Reduced readmission is, however, a
worthwhile aim of treatment. The benefit was seen in
older patients, many of whom were women. Both these
groups have been under›represented in trials of drugs
for heart failure.1
One limitation of our study is that it was conducted
before there was good evidence to support the general
use of â blockers for heart failure. One objective of
nurse intervention, however, is to increase the use of
effective treatments, and nurse intervention seems ide›
ally suited to facilitate the slow, cautious, up›titration
required with â blockers.
Other studies
Our study differs from three published randomised
trials of nurse intervention in heart failure.7–9 Cline et
al, in Sweden, used a clinic based nurse intervention.7
They found only a trend to reduced readmissions. In
the United States, Rich et al used a multidisciplinary
intervention involving a specially trained nurse,
dietician, geriatric cardiologist, social services, and
home care services.8 The intervention started before
discharge and was supplemented after discharge by
home visits and telephone contact with members of
the study team. The treatment objectives were similar
to ours, although it is difficult to tell from the published
report whether the level of nurse intervention was as
intensive. The benefit of intervention was less clear.
Among 282 patients randomised, survival free of
readmission at 90 days (the primary end point) was
54% in the control group and 64% in the treatment
group (not significant). The risk of readmission was
reduced (absolute risk reduction 13%, P = 0.03) and the
number of admissions for heart failure was halved.
Neither of these studies had a follow up of more than
six months.
Stewart et al, in Australia, reported a trial in 200
patients using an intervention consisting of only one
home visit by a nurse and pharmacist one week after
discharge.9 This intervention was similar to that used in
our study, although the continuing patient care was
devolved to other healthcare workers. More patients in
the usual care group than the intervention group had
an event within six months (51 v 38, P = 0.04), and the
intervention reduced the total number of events (129 v
77, P = 0.02).
Implications
Collectively, these studies suggest that, in addition to
education about heart failure and its treatment, the key
components of successful intervention are regular
contact with patients to detect clinical deterioration
and continued adjustment and optimisation of
treatment.5 9 In our study, the dose of angiotensin con›
verting enzyme inhibitor had increased more in the
intervention than in the usual care group, even before
discharge. This may have contributed to the reduction
in hospital admissions.10
Home visiting also seems to be pivotal to reducing
admissions, perhaps by ensuring regular and effective
patient contact.7 9 Nurses in our study could change
drug treatment, within predefined limits, without
medical consultation. This may have resulted in
problems such as sodium volume overload and
deteriorating renal function being corrected more rap›
idly. Interventions relying on patient initiated tele›
phone communication and visits to hospital clinics
may be less effective.
We thank Professors Dargie and Reid for their help in the plan›
ning and implementation of this study. We also thank the physi›
cians and nurses working in the acute medical admissions unit
and local general practitioners for allowing us to study their
patients. We thank A Trainer for additional statistical analysis.
Contributors: JJVMcM, CEM, and IF were involved in plan›
ning the study and wrote the study protocol. LB and EL were the
two specialist nurses. EC prepared summaries of all hospital
admissions for the end point committee (DRM, MCP, JJVMcM).
APD, TMcD, DRM, MCP, and JJVMcM provided medical
support for the nurses. JJVMcM and CEM supervised the study.
CER and IF helped organise data collection and set up the study
database. CER, JN, and IF carried out the statistical analysis. All
investigators were involved in writing the study report. JJVMcM
is the guarantor.
Funding: This study was supported by a grant from the
Scottish Office, Department of Health.
Competing interests: None declared.
1 McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart
failure. Heart 2000;83:596›602.
2 Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More ‘malig›
nant’ than cancer? Five›year survival following a first admission for heart
failure. Eur J Heart Fail 2001;3:315›22.
3 Ashton CM. Care of patients with failing hearts: evidence for failures in
clinical practice and health services research J Gen Intern Med 1999;14:
138›40.
4 Chin MH, Goldman L. Factors contributing to the hospitalization of
patients with congestive heart failure. Am J Public Health 1997;87:643›8.
5 McMurray JJ, Stewart S. Nurse led, multidisciplinary intervention in
chronic heart failure. Heart 1998;80:430›1.
6 Stewart S, Blue L, eds. Improving outcomes in chronic heart failure: a practical
guide to specialist nurse intervention. London: BMJ, 2001.
7 Cline CMJ, Israelsson BYA, Willenheimer RB, Broms K, Erhardt LR. Cost
effective management programme for heart failure reduces hospitalisa›
tion. Heart 1998;80:442›6.
8 Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney
RM. A multidisciplinary intervention to prevent the readmission of
elderly patients with congestive heart failure. N Engl J Med 1995;333:
1190›5.
9 Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary,
home›based intervention on unplanned readmissions and survival
among patients with chronic congestive heart failure: a randomised con›
trolled study. Lancet 1999;354:1077›83.
10 Packer M, Poole›Wilson PA, Armstrong PW, Cleland JG, Horowitz JD,
Massie BM, et al. Circulation 1999;100:2312›8.
(Accepted 10 July 2001)
What is already known on this topic
Studies have suggested that nurse intervention
may reduce readmission in patients with heart
failure
What this study adds
Home based intervention from nurses reduces
readmissions for worsening heart failure
Regular contact to review treatment and patient
education are likely to contribute to this effect
Endpiece
The danger of good people
Good people do a great deal of harm in the world.
Certainly the greatest harm they do is that they
make badness of such extraordinary importance.
Oscar Wilde, Lady Windermere’s Fan
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